(Q38973987)

English

Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways (English)

1 reference

Europe PubMed Central

8 September 2017

author name string

Jie Li

1

1 reference

Europe PubMed Central

8 September 2017

Xingxia Li

2

1 reference

Europe PubMed Central

8 September 2017

Weiheng Xu

3

1 reference

Europe PubMed Central

8 September 2017

Shaozhan Wang

4

1 reference

Europe PubMed Central

8 September 2017

Zhenlin Hu

5

1 reference

Europe PubMed Central

8 September 2017

Qing Zhang

6

1 reference

Europe PubMed Central

8 September 2017

Xing Deng

7

1 reference

Europe PubMed Central

8 September 2017

Jing Wang

8

1 reference

Europe PubMed Central

8 September 2017

Junping Zhang

9

1 reference

Europe PubMed Central

8 September 2017

Cheng Guo

10

1 reference

Europe PubMed Central

8 September 2017

publication date

5 August 2014

1 reference

Europe PubMed Central

8 September 2017

Liver International

1 reference

Europe PubMed Central

8 September 2017

35

1 reference

Europe PubMed Central

8 September 2017

4

1 reference

Europe PubMed Central

8 September 2017

1222-1233

1 reference

Europe PubMed Central

8 September 2017

Mechanisms of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Hepatic stellate cells as a target for the treatment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Mechanisms of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Transcriptional regulation of stellate cell activation

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Distribution and biological activities of the flavonoid luteolin

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Advances in flavonoid research since 1992.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Evaluation of the anti-inflammatory activity of luteolin in experimental animal models

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Pirfenidone effectively reverses experimental liver fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Adenoviral-mediated transfer of p53 or retinoblastoma protein blocks cell proliferation and induces apoptosis in culture-activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Anti-carcinogenic effects of the flavonoid luteolin.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Dose- and time-dependent effects of luteolin on liver metallothioneins and metals in carbon tetrachloride-induced hepatotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12638

21 January 2018

Identifiers

10.1111/LIV.12638

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38973987&oldid=1800041365"